87 FR 179 pgs. 56927-56928 - Foreign-Trade Zone (FTZ) 7—Mayaguez, Puerto Rico; Authorization of Production Activity; AbbVie Ltd. (Pharmaceutical Products), Barceloneta, Puerto Rico
Type: NOTICEVolume: 87Number: 179Pages: 56927 - 56928
Pages: 56927, 56928Docket number: [B-19-2022]
FR document: [FR Doc. 2022-20012 Filed 9-15-22; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-19-2022]
Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; AbbVie Ltd. (Pharmaceutical Products), Barceloneta, Puerto Rico
On May 13, 2022, AbbVie Ltd., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 7I, in Barceloneta, Puerto Rico.
[top] The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 30448, May 19, 2022). On September 12, 2022, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to
Dated: September 12, 2022.
Christopher Kemp,
Acting Executive Secretary.
[FR Doc. 2022-20012 Filed 9-15-22; 8:45 am]
BILLING CODE 3510-DS-P